205 related articles for article (PubMed ID: 27399121)
1. The effectiveness and safety of preoperative use of erythropoietin in patients scheduled for total hip or knee arthroplasty: A systematic review and meta-analysis of randomized controlled trials.
Zhao Y; Jiang C; Peng H; Feng B; Li Y; Weng X
Medicine (Baltimore); 2016 Jul; 95(27):e4122. PubMed ID: 27399121
[TBL] [Abstract][Full Text] [Related]
2. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.
Bedair H; Yang J; Dwyer MK; McCarthy JC
Clin Orthop Relat Res; 2015 Feb; 473(2):590-6. PubMed ID: 25106796
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis and systematic review evaluating the use of erythropoietin in total hip and knee arthroplasty.
Li Y; Yin P; Lv H; Meng Y; Zhang L; Tang P
Ther Clin Risk Manag; 2018; 14():1191-1204. PubMed ID: 30022832
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Voorn VM; van der Hout A; So-Osman C; Vliet Vlieland TP; Nelissen RG; van den Akker-van Marle ME; Dahan A; Marang-van de Mheen PJ; van Bodegom-Vos L
Vox Sang; 2016 Oct; 111(3):219-225. PubMed ID: 27314459
[TBL] [Abstract][Full Text] [Related]
5. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
6. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
Green WS; Toy P; Bozic KJ
J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
[TBL] [Abstract][Full Text] [Related]
7. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
[TBL] [Abstract][Full Text] [Related]
8. Is There a Role for Preoperative Iron Supplementation in Patients Preparing for a Total Hip or Total Knee Arthroplasty?
Petis SM; Lanting BA; Vasarhelyi EM; Naudie DDR; Ralley FE; Howard JL
J Arthroplasty; 2017 Sep; 32(9):2688-2693. PubMed ID: 28529107
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.
Voorn VMA; Marang-van de Mheen PJ; van der Hout A; Hofstede SN; So-Osman C; van den Akker-van Marle ME; Kaptein AA; Stijnen T; Koopman-van Gemert AWMM; Dahan A; Vliet Vlieland TPMM; Nelissen RGHH; van Bodegom-Vos L
Implement Sci; 2017 May; 12(1):72. PubMed ID: 28558843
[TBL] [Abstract][Full Text] [Related]
10. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials.
Alsaleh K; Alotaibi GS; Almodaimegh HS; Aleem AA; Kouroukis CT
J Arthroplasty; 2013 Oct; 28(9):1463-72. PubMed ID: 23528548
[TBL] [Abstract][Full Text] [Related]
11. Effect of erythropoietin on perioperative blood transfusions in primary total hip arthroplasty: A systematic review.
Abram D; Tran MH
Transfus Apher Sci; 2023 Aug; 62(4):103718. PubMed ID: 37173207
[TBL] [Abstract][Full Text] [Related]
12. Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
Biboulet P; Motais C; Pencole M; Karam O; Dangelser G; Smilevitch P; Maissiat G; Capdevila X; Bringuier S
Transfusion; 2020 Aug; 60(8):1732-1740. PubMed ID: 32681743
[TBL] [Abstract][Full Text] [Related]
13. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
Couvret C; Laffon M; Baud A; Payen V; Burdin P; Fusciardi J
Anesth Analg; 2004 Jul; 99(1):262-271. PubMed ID: 15281542
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of erythropoietin use in orthopaedic surgery.
Coyle D; Lee KM; Fergusson DA; Laupacis A
Transfus Med; 1999 Mar; 9(1):21-30. PubMed ID: 10216902
[TBL] [Abstract][Full Text] [Related]
15. Potential cost saving of Epoetin alfa in elective hip or knee surgery due to reduction in blood transfusions and their side effects: a discrete-event simulation model.
Tomeczkowski J; Stern S; Müller A; von Heymann C
PLoS One; 2013; 8(9):e72949. PubMed ID: 24039829
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: a meta-analysis.
Ho KM; Ismail H
Anaesth Intensive Care; 2003 Oct; 31(5):529-37. PubMed ID: 14601276
[TBL] [Abstract][Full Text] [Related]
17. A protocol avoiding allogeneic transfusion in joint arthroplasties.
Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
Polanco-García M; Capielo AM; Miret X; Chamero A; Sainz J; Revilla E; Guinjoan A; Arranz T
Med Clin (Barc); 2019 Feb; 152(3):90-97. PubMed ID: 29887176
[TBL] [Abstract][Full Text] [Related]
19. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
Bezwada HP; Nazarian DG; Henry DH; Booth RE
J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840
[TBL] [Abstract][Full Text] [Related]
20. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty.
Newman ET; Watters TS; Lewis JS; Jennings JM; Wellman SS; Attarian DE; Grant SA; Green CL; Vail TP; Bolognesi MP
J Bone Joint Surg Am; 2014 Feb; 96(4):279-84. PubMed ID: 24553883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
